Medicinova

MNOVNasdaq United States Health Care Biotechnology: Pharmaceutical Preparations

Market cap

$142.742 M

$2.90 -12.12%

Close of 22 Sept 2026

Revenue

$409.7K

#3541 by revenue

Earnings

$12.0M

#2011 by earnings

Shares outstanding

49,221,246

Latest filing cover page

P/E ratio

11.9

Cap ÷ net income

Biotechnology: Pharmaceutical Preparations, ranked by market cap

All 499 →

#287NRX PharmaceuticalsNRXP$143.7M
#288Spruce BiosciencesSPRB$143.7M
#289MedicinovaMNOV$142.7M
#290Unicycive TherapeuticsUNCY$138.2M
#291TuHURA BiosciencesHURA$135.7M

What if Medicinova were worth as much as…

Open the what-if tool →

Gold $30.2T

$614,246.33

Per share 211,809× higher

Bitcoin $1.74T

$35,384.21

Per share 12,201× higher

Nvidia $5.52T

$112,060.69

Per share 38,642× higher

Or at a round number

$200.0M $500.0M $1.00B $2.00B

Where these numbers come from

Share counts and financials for Medicinova are taken from its own SEC filings via EDGAR: public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Last updated 23 Sept 2026. Read the methodology.